Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
04/2014
04/23/2014CN103734137A Piperazin derivatives and their use in controlling pests
04/23/2014CN102675246B Preparation method of pramoxine hydrochloride
04/22/2014CA2419995C New polyol ester derivatives of polyamines and use in turbine oils to improve cleanliness
04/17/2014WO2014059346A1 Methods for the treatment of conditions involving dopamine through administration of piperazine compounds
04/17/2014WO2014059338A1 Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
04/17/2014WO2014058071A1 Cyclopropanamine compound and use thereof
04/17/2014WO2014057266A1 Acylpiperazines as inhibitors of transglutaminase and their use in medicine
04/17/2014WO2014057080A2 Cyclic amines
04/17/2014US20140107336 Tri-aryl compounds and compositions comprising the same
04/17/2014US20140107335 Cyclic Amines
04/17/2014US20140107129 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
04/17/2014US20140107119 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
04/17/2014US20140107110 Anti-fibrotic pyridinones
04/17/2014US20140107027 Methods and compositions for treating amyloid-related diseases
04/16/2014EP2718253A1 Partially fluorinated ketones and methods of making and using the same
04/16/2014CN103732584A Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
04/16/2014CN103724360A Pyridine (or benzene) thiazole compound shown and intermediate, preparation method and application thereof
04/16/2014CN103724296A Aryl substituted piperazine carbonyl derivative as well as preparation method and application thereof
04/16/2014CN103724295A Method for preparing linezolid intermediate
04/16/2014CN103724294A Novel preparation method of quetiapine
04/16/2014CN102895974B Method for synthesizing N-methyl piperidine and supported catalyst used by the method
04/16/2014CN102872873B Method for synthesizing 1, 2-dipiperidinoethane and catalyst thereof
04/16/2014CN102796061B Synthesis method of N,N '-dialky piperazine
04/16/2014CN102702138B Repaglinide compound and novel production method thereof
04/16/2014CN102659717B Synthetic method of 2-methyl-1-(4'-methylthiophenyl)-2-morpholinyl-1-acetone
04/16/2014CN102603555B All-trans retinoic acid amide derivative and preparation method and application thereof
04/15/2014US8697717 Inhibitors of histone deacetylase
04/15/2014US8697684 Azetidinyl diamides as monoacylglycerol lipase inhibitors
04/15/2014US8697604 Labeling agents for mass spectrometry comprising tertiary amines
04/15/2014CA2730478C Prodrugs of methyl hydrogen fumarate
04/10/2014US20140100366 Process for making thienopyrimidine compounds
04/10/2014US20140100227 C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
04/10/2014US20140100215 Methods of Using PI3K and MEK Modulators
04/09/2014EP2714665A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
04/09/2014CN103709123A 1, 4-dimethyl-1-alkyl piperazine ionic liquid as well as preparation method and applications thereof
04/09/2014CN103709096A Urea type derivative used as nicotinamide ribose phosphate transferase inhibitor, as well as preparation method and application thereof
04/09/2014CN103709052A Rhein amino-alcohol ester type compound, and preparation method and pharmaceutical application thereof
04/09/2014CN102483572B Photopolymerizable composition, color filter, method for producing same, solid-state image pickup element, liquid crystal display device, lithographic printing original plate, and novel compound
04/09/2014CN102250041B Pyrrolidine ionic compounds containing phenoxy substituents, and preparation method thereof
04/09/2014CN102241646B Hexenone compound, and medical purpose thereof
04/09/2014CN101370773B Cycloalkanecarboxamide derivative and method for producing same
04/08/2014US8691993 Piperidinyl naphthylacetic acids
04/08/2014US8691977 Certain chemical entities, compositions, and methods
04/03/2014WO2014052659A1 Crystalline forms of neurotrophin mimetic compounds and their salts
04/03/2014WO2014048165A1 Compound as potassium channel modulator
04/03/2014WO2013013861A3 Novel oxidation dye precursors
04/03/2014US20140094492 Derivatives of sulindac, use thereof and preparation thereof
04/03/2014US20140094465 Compounds as S-Nitrosoglutathione Reductase Inhibitors
04/03/2014US20140094464 Quinone compounds for treating ape1 mediated diseases
04/03/2014US20140094445 Substituted (e)-n'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors
04/03/2014US20140094399 Biodegradable poly(beta-amino esters) and uses thereof
04/02/2014CN103694163A Compounds capable of being adopted as potassium channel modulators
04/02/2014CN102603675B Piperazine compound and application thereof
04/02/2014CN102489282B Dewatering catalyst and application thereof in preparing morpholine
04/02/2014CN102408395B Novel piperazine and homopiperazine derivative and preparation method and use thereof
04/02/2014CN102351811B Ester derivative of rupestonic acid, and preparation method and purpose thereof
04/02/2014CN102143750B Macrocyclics pyrimidines as aurora kinase inhibitors
04/01/2014US8686154 Compounds and compositions for delivering active agents
04/01/2014US8686134 Ionic liquids
04/01/2014US8686032 Enzyme inhibitors
04/01/2014US8686008 Highly selective sigma receptor ligands
04/01/2014US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/2014
03/27/2014WO2014044721A1 Novel crystalline form of vortioxetine hydrobromide
03/27/2014US20140088106 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/27/2014US20140088100 Inhibitors of the fibroblast growth factor receptor
03/27/2014US20140088074 Fluorinated arylalkylaminocarboxamide derivatives
03/27/2014US20140086834 New i-arylpiperazinic ligands of 5-ht7 receptor and use thereof
03/26/2014EP2710892A2 Use of sarmentine and its analogs for controlling plant pests
03/26/2014CN103664951A Preparation method of drug for treating chronic granulocytic leukemia
03/26/2014CN103664830A Improved synthetic method of cinepazide maleate
03/26/2014CN103664829A Ranolazine synthesis technology
03/26/2014CN103664828A Method for preparing high-purity repaglinide
03/26/2014CN103664827A Method for compounding photo-initiator
03/26/2014CN103664826A Preparation method for aminonaphthol compound
03/26/2014CN103664723A Preparation methods of dithiocarbamic acid metal salt solution and metal sulfide nano material
03/26/2014CN103664646A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/26/2014CN102887836B L-phenylglycine derivative and application thereof
03/25/2014US8680100 Sulfonylhydrazide compounds for treating proliferative disorders
03/25/2014US8679776 Activatable dyes
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014CA2737282C Aryl sulfonamide amine compounds and their use as 5-ht6 ligands
03/25/2014CA2665428C Hdac inhibitors
03/25/2014CA2591757C Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
03/25/2014CA2585983C Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
03/25/2014CA2379891C Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
03/20/2014WO2014041424A1 Histone deacetylase inhibitors for enhancing activity of antifungal agents
03/20/2014US20140081017 Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents
03/20/2014US20140080833 Intracellular kinase inhibitors
03/20/2014US20140080832 IRE-1alpha INHIBITORS
03/20/2014US20140080824 Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080802 Inhibitors of Histone Deacetylase
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/19/2014CN103641797A Preparation method for N-acetyl morpholine
03/19/2014CN103641751A Alkali metal salts of binary or ternary fluorine-containing sulfimide and ionic liquid and applications thereof
03/19/2014CN103638871A Double spacer group-containing surfactant prepared from N, N'-dimethyl-piperazine and preparation method thereof
03/19/2014CN103638779A Renewable organic amine flue gas desulfurization agent and preparation method thereof
03/19/2014CN102766112B Synthetic method of repaglinide
03/19/2014CN102627518B Preparation method of N-nitrosamine
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 341